Keyphrases
Neonatal Lung
100%
Redox Regulation
100%
Soluble Guanylate Cyclase
100%
CGMP Signaling
100%
Pulmonary Hypertension
85%
Alveolarization
85%
Hyperoxia
85%
Bronchopulmonary Dysplasia
71%
Phosphodiesterase Type 5 Inhibitors
57%
Right Ventricular Hypertrophy
42%
Selective Intrauterine Growth Restriction (sIUGR)
42%
Lung
28%
Angiogenesis
28%
Pulmonary Artery
28%
Growth Restriction
28%
Reactive Oxygen Species
28%
Growth Factors
28%
Mouse Model
28%
Cyclic GMP
14%
Capillary Density
14%
Signaling Pathway
14%
Molecular Mechanism
14%
Sildenafil
14%
Preterm Birth
14%
Downstream Signaling
14%
Pulmonary Vascular Remodeling
14%
Neonatal Period
14%
Mechanical Ventilation
14%
Reactive Oxygen Species Production
14%
Alveolar Simplification
14%
Environmental Stressors
14%
Neonate
14%
Lung Growth
14%
O2 Concentration
14%
Pulmonary Vasculature
14%
Placental Insufficiency
14%
Common Complications
14%
Multiple Signals
14%
Capillary
14%
Hyperoxia-induced Lung Injury
14%
Soluble Guanylate Cyclase Stimulator
14%
Mitochondrial Reactive Oxygen Species (mtROS)
14%
Pathophysiologic
14%
Decreased Expression
14%
Insulin-like
14%
Dysregulation
14%
Birth Weight
14%
Therapeutic Potential
14%
Pharmacological Therapy
14%
Vascular Disease
14%
Pulmonary Disease
14%
Lung Development
14%
Vascular Remodeling
14%
Lung Disease
14%
Vascular Dysfunction
14%
Medicine and Dentistry
Guanylate Cyclase
100%
Lung
100%
Pulmonary Hypertension
75%
Alveolarization
75%
Hyperoxia
75%
Lung Dysplasia
62%
Reactive Oxygen Species
50%
Pulmonary Artery
37%
Intrauterine Growth Retardation
37%
Right Ventricular Hypertrophy
37%
Phosphodiesterase V
37%
Silo-Filler's Disease
25%
Lung Artery
25%
Capillary
25%
Angiogenesis
25%
Neonates
12%
Newborn Period
12%
Guanylate Cyclase Activator
12%
Low Drug Dose
12%
Artificial Respiration
12%
Somatomedin C
12%
Birth Weight
12%
Placental Insufficiency
12%
Hyperoxia-Induced Lung Injury
12%
Lung Development
12%
Phosphodiesterase V Inhibitor
12%
Pulmonary Vasculature
12%
Premature Labor
12%
Vascular Remodeling
12%
Vascular Disease
12%
Signal Transduction
12%
Sildenafil
12%
Growth Factor
12%
Pharmacology, Toxicology and Pharmaceutical Science
Guanylate Cyclase
100%
Pulmonary Hypertension
75%
Lung Dysplasia
62%
Reactive Oxygen Metabolite
50%
Intrauterine Growth Retardation
37%
Phosphodiesterase V
37%
Heart Right Ventricle Hypertrophy
37%
Mouse Model
25%
Lung Disease
25%
Sildenafil
12%
Vascular Remodeling
12%
Guanylate Cyclase Activator
12%
Placenta Insufficiency
12%
Hyperoxia-Induced Lung Injury
12%
Premature Labor
12%
Phosphodiesterase V Inhibitor
12%
Growth Factor
12%
Somatomedin C
12%
Vascular Disease
12%